• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB

DIMERIX LIMITED - Announcements

1.96% ! 52.0¢
Market Cap $312.0M  !

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

Announcements



DXB Change of Director's Interest Notice11/09/18 download Created with Sketch. 200.78KB
DXB Annual Report to shareholders30/08/18 download Created with Sketch. 1.12MB
DXB Appendix 4G and Corporate Governance Statement30/08/18 download Created with Sketch. 532.72KB
DXB Preliminary Final ReportPRICE SENSITIVE30/08/18 download Created with Sketch. 151.46KB
DXB Initial Director's Interest Notice28/08/18 download Created with Sketch. 145.64KB
DXB EXECUTIVE TEAM BOLSTERED THROUGH CEO & MD APPOINTMENTPRICE SENSITIVE27/08/18 download Created with Sketch. 155.28KB
DXB Quarterly Review & Appendix 4CPRICE SENSITIVE31/07/18 download Created with Sketch. 380.79KB
DXB Company Presentation27/07/18 download Created with Sketch. 8.37MB
DXB Change of Director Interest Notices x 224/07/18 download Created with Sketch. 310.07KB
DXB Ethics Approval Received Appendix 3B and S.708A NoticePRICE SENSITIVE18/07/18 download Created with Sketch. 732.36KB
DXB Further US patent allowed for DMX-200PRICE SENSITIVE02/07/18 download Created with Sketch. 66.48KB
DXB Investor Presentation20/06/18 download Created with Sketch. 1.94MB
DXB Change of Director's Interest Notice30/05/18 download Created with Sketch. 203.48KB
DXB Change of Director's Interest Notice29/05/18 download Created with Sketch. 205.26KB
DXB Dual Phase 2 trials launched for CKDPRICE SENSITIVE15/05/18 download Created with Sketch. 100.67KB
DXB LEAD INVESTIGATOR ENGAGED FOR NEXT STAGE OF DMX-200 TRIALS07/05/18 download Created with Sketch. 71.85KB
DXB Completion of Unmarketable Parcel Sale Facility02/05/18 download Created with Sketch. 123.79KB
DXB Dimerix to Further Bolster Management Team30/04/18 download Created with Sketch. 64.1KB
DXB Quarterly Review & Appendix 4CPRICE SENSITIVE27/04/18 download Created with Sketch. 374.85KB
DXB NDF Research updated analyst coverage13/04/18 download Created with Sketch. 196.23KB
DXB Westar Capital Retained as Corporate AdvisorsPRICE SENSITIVE12/04/18 download Created with Sketch. 125.41KB
DXB CMO Appointment and Clinical Trials UpdatePRICE SENSITIVE27/03/18 download Created with Sketch. 183.95KB
DXB Channel 7 News Segment13/03/18 download Created with Sketch. 338.67KB
DXB Unmarketable Parcel Share Sale Facility09/03/18 download Created with Sketch. 341.23KB
DXB Ceasing to be a substantial holder01/03/18 download Created with Sketch. 68.33KB
DXB Change in substantial holding28/02/18 download Created with Sketch. 48.57KB
DXB LR 3.10.5A Disclosure28/02/18 download Created with Sketch. 121.15KB
DXB Appendix 3B and Cleansing Notice28/02/18 download Created with Sketch. 534.44KB
DXB Change in substantial holding27/02/18 download Created with Sketch. 48.41KB
DXB Half Year Report and Financial StatementsPRICE SENSITIVE26/02/18 download Created with Sketch. 1.7MB
DXB Oversubscribed Placement to Raise a Further $4.5mPRICE SENSITIVE21/02/18 download Created with Sketch. 157.84KB
DXB Trading HaltPRICE SENSITIVE19/02/18 download Created with Sketch. 181.58KB
DXB Corporate Presentation05/02/18 download Created with Sketch. 3.31MB
DXB Change of Director's Interest Notice x 230/01/18 download Created with Sketch. 558.67KB
DXB Quarterly Review and Appendix 4CPRICE SENSITIVE29/01/18 download Created with Sketch. 677.71KB
DXB Appendix 3B25/01/18 download Created with Sketch. 715.81KB
DXB Results of Entitlement OfferPRICE SENSITIVE24/01/18 download Created with Sketch. 124.38KB
DXB Recorded interview with CEO and rights issue update16/01/18 download Created with Sketch. 451.04KB
DXB DMX-200 Dosage Optimisation Study Successfully CompletedPRICE SENSITIVE08/01/18 download Created with Sketch. 340.34KB
DXB Appendix 3B08/01/18 download Created with Sketch. 707.14KB
DXB Proteomics partners diagnostic test with Dimerix kidney drug14/12/17 download Created with Sketch. 233.2KB
DXB Proteomics partnership to improve treatment of CKDPRICE SENSITIVE14/12/17 download Created with Sketch. 134.42KB
DXB Dispatch of Offer Document and Entitlement and Forms13/12/17 download Created with Sketch. 22.83KB
DXB Audio interview with CEO11/12/17 download Created with Sketch. 426.53KB
DXB Reinstatement to Official QuotationPRICE SENSITIVE06/12/17 download Created with Sketch. 87.78KB
DXB Letters to Shareholders and Option Holders06/12/17 download Created with Sketch. 597.99KB
DXB Appendix 3B06/12/17 download Created with Sketch. 716.09KB
DXB Entitlement Offer BookletPRICE SENSITIVE06/12/17 download Created with Sketch. 723.42KB
DXB Cleansing Notice06/12/17 download Created with Sketch. 208.16KB
DXB Entitlement Offer to raise $5.5 millionPRICE SENSITIVE06/12/17 download Created with Sketch. 51.89KB
DXB Suspension from Official QuotationPRICE SENSITIVE05/12/17 download Created with Sketch. 685.45KB
DXB Trading HaltPRICE SENSITIVE01/12/17 download Created with Sketch. 465.66KB
DXB Dimerix Presenting at World Diabetes Congress27/11/17 download Created with Sketch. 748.45KB
DXB Change of Director's Interest Notices X 423/11/17 download Created with Sketch. 873.96KB
DXB Corporate Presentation22/11/17 download Created with Sketch. 3.16MB
DXB Appendix 3B17/11/17 download Created with Sketch. 714.68KB
DXB Appendix 3B and Cleansing Statement10/11/17 download Created with Sketch. 1.15MB
DXB Updated Equity Research Report Published08/11/17 download Created with Sketch. 339.56KB
DXB Corporate Presentation BioEurope08/11/17 download Created with Sketch. 2.79MB
DXB Baker Young Stockbroking Issues Flash Note Report06/11/17 download Created with Sketch. 263.16KB
DXB DMX-200 Phase 2a Data Presentation02/11/17 download Created with Sketch. 4.23MB
DXB Dimerix Phase 2a Subgroup Analysis ResultsPRICE SENSITIVE02/11/17 download Created with Sketch. 485.66KB
DXB Quarterly Review and Appendix 4CPRICE SENSITIVE31/10/17 download Created with Sketch. 740.98KB
DXB Securities on Issue Post Consolidation31/10/17 download Created with Sketch. 527.05KB
DXB Baker Young Stockbroking initiates coverage on Dimerix24/10/17 download Created with Sketch. 482.39KB
DXB Ethics Committee Approval for Pharmacokinetic TrialPRICE SENSITIVE24/10/17 download Created with Sketch. 337.67KB
DXB Update - Consolidation/Split - DXB19/10/17 download Created with Sketch. 43.33KB
DXB Results of Meeting19/10/17 download Created with Sketch. 433.99KB
DXB AGM Presentation19/10/17 download Created with Sketch. 3.09MB
DXB Dimerix Appoints Medical Advisory Board18/10/17 download Created with Sketch. 451.82KB
DXB Dimerix Receives $545k R&D Tax RefundPRICE SENSITIVE17/10/17 download Created with Sketch. 491.55KB
DXB Shareholder Update27/09/17 download Created with Sketch. 1.91MB
DXB Notice of Annual General Meeting - corrected13/09/17 download Created with Sketch. 1.37MB
DXB Consolidation/Split - DXB13/09/17 download Created with Sketch. 25.22KB
DXB Investor Presentation13/09/17 download Created with Sketch. 2.54MB
DXB Notice of Annual General Meeting/Proxy FormPRICE SENSITIVE13/09/17 download Created with Sketch. 1.37MB
DXB DMX-200 tablet manufacture and human study timelinePRICE SENSITIVE05/09/17 download Created with Sketch. 268.97KB
DXB Appendix 4G and Corporate Governance Statement30/08/17 download Created with Sketch. 1.03MB
DXB Annual Report to shareholders30/08/17 download Created with Sketch. 3.95MB
DXB Preliminary Final ReportPRICE SENSITIVE30/08/17 download Created with Sketch. 395.33KB
DXB Appendix 3B16/08/17 download Created with Sketch. 857.51KB
DXB DMX-200 Phase 2a Data Presentation16/08/17 download Created with Sketch. 336.45KB
DXB Board Restructure and Incentive Package for CEO01/08/17 download Created with Sketch. 334.47KB
DXB Appendix 4C - quarterlyPRICE SENSITIVE31/07/17 download Created with Sketch. 416.41KB
DXB Phase 2a Trial Result Release Interview Video Recording17/07/17 download Created with Sketch. 52.3KB
DXB Phase 2a Trial Result Release Conference Call Recording13/07/17 download Created with Sketch. 45.97KB
DXB DMX-200 Phase 2a Trial - Investor Presentation12/07/17 download Created with Sketch. 2.6MB
DXB Positive Results from Phase 2a Trial of DMX-200PRICE SENSITIVE12/07/17 download Created with Sketch. 454.66KB
DXB Trading HaltPRICE SENSITIVE11/07/17 download Created with Sketch. 641.41KB
DXB Change of director interest notices x 306/07/17 download Created with Sketch. 768.77KB
DXB Appendix 3B03/07/17 download Created with Sketch. 717.14KB
DXB Gold Coast Investment Showcase Presentation22/06/17 download Created with Sketch. 2.6MB
DXB CEO Interview14/06/17 download Created with Sketch. 330.92KB
DXB Research Validates Relevance of DMX Receptor-HIT TechnologyPRICE SENSITIVE13/06/17 download Created with Sketch. 298.86KB
DXB Dimerix Hosts US Key Opinion Leader Meeting06/06/17 download Created with Sketch. 365.19KB
DXB Shareholder Briefing16/05/17 download Created with Sketch. 733.37KB
DXB Initial Director's Interest Notice01/05/17 download Created with Sketch. 284.68KB
DXB Director Appointment01/05/17 download Created with Sketch. 337.29KB
DXB Appendix 4C - quarterlyPRICE SENSITIVE28/04/17 download Created with Sketch. 232.69KB
DXB Investor UpdatePRICE SENSITIVE11/04/17 download Created with Sketch. 1.49MB
DXB Change of Director's Interest Notice
11/09/18 download Created with Sketch. 200.78KB
DXB Annual Report to shareholders
30/08/18 download Created with Sketch. 1.12MB
DXB Appendix 4G and Corporate Governance Statement
30/08/18 download Created with Sketch. 532.72KB
DXB Preliminary Final Report
30/08/18PRICE SENSITIVE download Created with Sketch. 151.46KB
DXB Initial Director's Interest Notice
28/08/18 download Created with Sketch. 145.64KB
DXB EXECUTIVE TEAM BOLSTERED THROUGH CEO & MD APPOINTMENT
27/08/18PRICE SENSITIVE download Created with Sketch. 155.28KB
DXB Quarterly Review & Appendix 4C
31/07/18PRICE SENSITIVE download Created with Sketch. 380.79KB
DXB Company Presentation
27/07/18 download Created with Sketch. 8.37MB
DXB Change of Director Interest Notices x 2
24/07/18 download Created with Sketch. 310.07KB
DXB Ethics Approval Received Appendix 3B and S.708A Notice
18/07/18PRICE SENSITIVE download Created with Sketch. 732.36KB
DXB Further US patent allowed for DMX-200
02/07/18PRICE SENSITIVE download Created with Sketch. 66.48KB
DXB Investor Presentation
20/06/18 download Created with Sketch. 1.94MB
DXB Change of Director's Interest Notice
30/05/18 download Created with Sketch. 203.48KB
DXB Change of Director's Interest Notice
29/05/18 download Created with Sketch. 205.26KB
DXB Dual Phase 2 trials launched for CKD
15/05/18PRICE SENSITIVE download Created with Sketch. 100.67KB
DXB LEAD INVESTIGATOR ENGAGED FOR NEXT STAGE OF DMX-200 TRIALS
07/05/18 download Created with Sketch. 71.85KB
DXB Completion of Unmarketable Parcel Sale Facility
02/05/18 download Created with Sketch. 123.79KB
DXB Dimerix to Further Bolster Management Team
30/04/18 download Created with Sketch. 64.1KB
DXB Quarterly Review & Appendix 4C
27/04/18PRICE SENSITIVE download Created with Sketch. 374.85KB
DXB NDF Research updated analyst coverage
13/04/18 download Created with Sketch. 196.23KB
DXB Westar Capital Retained as Corporate Advisors
12/04/18PRICE SENSITIVE download Created with Sketch. 125.41KB
DXB CMO Appointment and Clinical Trials Update
27/03/18PRICE SENSITIVE download Created with Sketch. 183.95KB
DXB Channel 7 News Segment
13/03/18 download Created with Sketch. 338.67KB
DXB Unmarketable Parcel Share Sale Facility
09/03/18 download Created with Sketch. 341.23KB
DXB Ceasing to be a substantial holder
01/03/18 download Created with Sketch. 68.33KB
DXB Change in substantial holding
28/02/18 download Created with Sketch. 48.57KB
DXB LR 3.10.5A Disclosure
28/02/18 download Created with Sketch. 121.15KB
DXB Appendix 3B and Cleansing Notice
28/02/18 download Created with Sketch. 534.44KB
DXB Change in substantial holding
27/02/18 download Created with Sketch. 48.41KB
DXB Half Year Report and Financial Statements
26/02/18PRICE SENSITIVE download Created with Sketch. 1.7MB
DXB Oversubscribed Placement to Raise a Further $4.5m
21/02/18PRICE SENSITIVE download Created with Sketch. 157.84KB
DXB Trading Halt
19/02/18PRICE SENSITIVE download Created with Sketch. 181.58KB
DXB Corporate Presentation
05/02/18 download Created with Sketch. 3.31MB
DXB Change of Director's Interest Notice x 2
30/01/18 download Created with Sketch. 558.67KB
DXB Quarterly Review and Appendix 4C
29/01/18PRICE SENSITIVE download Created with Sketch. 677.71KB
DXB Appendix 3B
25/01/18 download Created with Sketch. 715.81KB
DXB Results of Entitlement Offer
24/01/18PRICE SENSITIVE download Created with Sketch. 124.38KB
DXB Recorded interview with CEO and rights issue update
16/01/18 download Created with Sketch. 451.04KB
DXB DMX-200 Dosage Optimisation Study Successfully Completed
08/01/18PRICE SENSITIVE download Created with Sketch. 340.34KB
DXB Appendix 3B
08/01/18 download Created with Sketch. 707.14KB
DXB Proteomics partners diagnostic test with Dimerix kidney drug
14/12/17 download Created with Sketch. 233.2KB
DXB Proteomics partnership to improve treatment of CKD
14/12/17PRICE SENSITIVE download Created with Sketch. 134.42KB
DXB Dispatch of Offer Document and Entitlement and Forms
13/12/17 download Created with Sketch. 22.83KB
DXB Audio interview with CEO
11/12/17 download Created with Sketch. 426.53KB
DXB Reinstatement to Official Quotation
06/12/17PRICE SENSITIVE download Created with Sketch. 87.78KB
DXB Letters to Shareholders and Option Holders
06/12/17 download Created with Sketch. 597.99KB
DXB Appendix 3B
06/12/17 download Created with Sketch. 716.09KB
DXB Entitlement Offer Booklet
06/12/17PRICE SENSITIVE download Created with Sketch. 723.42KB
DXB Cleansing Notice
06/12/17 download Created with Sketch. 208.16KB
DXB Entitlement Offer to raise $5.5 million
06/12/17PRICE SENSITIVE download Created with Sketch. 51.89KB
DXB Suspension from Official Quotation
05/12/17PRICE SENSITIVE download Created with Sketch. 685.45KB
DXB Trading Halt
01/12/17PRICE SENSITIVE download Created with Sketch. 465.66KB
DXB Dimerix Presenting at World Diabetes Congress
27/11/17 download Created with Sketch. 748.45KB
DXB Change of Director's Interest Notices X 4
23/11/17 download Created with Sketch. 873.96KB
DXB Corporate Presentation
22/11/17 download Created with Sketch. 3.16MB
DXB Appendix 3B
17/11/17 download Created with Sketch. 714.68KB
DXB Appendix 3B and Cleansing Statement
10/11/17 download Created with Sketch. 1.15MB
DXB Updated Equity Research Report Published
08/11/17 download Created with Sketch. 339.56KB
DXB Corporate Presentation BioEurope
08/11/17 download Created with Sketch. 2.79MB
DXB Baker Young Stockbroking Issues Flash Note Report
06/11/17 download Created with Sketch. 263.16KB
DXB DMX-200 Phase 2a Data Presentation
02/11/17 download Created with Sketch. 4.23MB
DXB Dimerix Phase 2a Subgroup Analysis Results
02/11/17PRICE SENSITIVE download Created with Sketch. 485.66KB
DXB Quarterly Review and Appendix 4C
31/10/17PRICE SENSITIVE download Created with Sketch. 740.98KB
DXB Securities on Issue Post Consolidation
31/10/17 download Created with Sketch. 527.05KB
DXB Baker Young Stockbroking initiates coverage on Dimerix
24/10/17 download Created with Sketch. 482.39KB
DXB Ethics Committee Approval for Pharmacokinetic Trial
24/10/17PRICE SENSITIVE download Created with Sketch. 337.67KB
DXB Update - Consolidation/Split - DXB
19/10/17 download Created with Sketch. 43.33KB
DXB Results of Meeting
19/10/17 download Created with Sketch. 433.99KB
DXB AGM Presentation
19/10/17 download Created with Sketch. 3.09MB
DXB Dimerix Appoints Medical Advisory Board
18/10/17 download Created with Sketch. 451.82KB
DXB Dimerix Receives $545k R&D Tax Refund
17/10/17PRICE SENSITIVE download Created with Sketch. 491.55KB
DXB Shareholder Update
27/09/17 download Created with Sketch. 1.91MB
DXB Notice of Annual General Meeting - corrected
13/09/17 download Created with Sketch. 1.37MB
DXB Consolidation/Split - DXB
13/09/17 download Created with Sketch. 25.22KB
DXB Investor Presentation
13/09/17 download Created with Sketch. 2.54MB
DXB Notice of Annual General Meeting/Proxy Form
13/09/17PRICE SENSITIVE download Created with Sketch. 1.37MB
DXB DMX-200 tablet manufacture and human study timeline
05/09/17PRICE SENSITIVE download Created with Sketch. 268.97KB
DXB Appendix 4G and Corporate Governance Statement
30/08/17 download Created with Sketch. 1.03MB
DXB Annual Report to shareholders
30/08/17 download Created with Sketch. 3.95MB
DXB Preliminary Final Report
30/08/17PRICE SENSITIVE download Created with Sketch. 395.33KB
DXB Appendix 3B
16/08/17 download Created with Sketch. 857.51KB
DXB DMX-200 Phase 2a Data Presentation
16/08/17 download Created with Sketch. 336.45KB
DXB Board Restructure and Incentive Package for CEO
01/08/17 download Created with Sketch. 334.47KB
DXB Appendix 4C - quarterly
31/07/17PRICE SENSITIVE download Created with Sketch. 416.41KB
DXB Phase 2a Trial Result Release Interview Video Recording
17/07/17 download Created with Sketch. 52.3KB
DXB Phase 2a Trial Result Release Conference Call Recording
13/07/17 download Created with Sketch. 45.97KB
DXB DMX-200 Phase 2a Trial - Investor Presentation
12/07/17 download Created with Sketch. 2.6MB
DXB Positive Results from Phase 2a Trial of DMX-200
12/07/17PRICE SENSITIVE download Created with Sketch. 454.66KB
DXB Trading Halt
11/07/17PRICE SENSITIVE download Created with Sketch. 641.41KB
DXB Change of director interest notices x 3
06/07/17 download Created with Sketch. 768.77KB
DXB Appendix 3B
03/07/17 download Created with Sketch. 717.14KB
DXB Gold Coast Investment Showcase Presentation
22/06/17 download Created with Sketch. 2.6MB
DXB CEO Interview
14/06/17 download Created with Sketch. 330.92KB
DXB Research Validates Relevance of DMX Receptor-HIT Technology
13/06/17PRICE SENSITIVE download Created with Sketch. 298.86KB
DXB Dimerix Hosts US Key Opinion Leader Meeting
06/06/17 download Created with Sketch. 365.19KB
DXB Shareholder Briefing
16/05/17 download Created with Sketch. 733.37KB
DXB Initial Director's Interest Notice
01/05/17 download Created with Sketch. 284.68KB
DXB Director Appointment
01/05/17 download Created with Sketch. 337.29KB
DXB Appendix 4C - quarterly
28/04/17PRICE SENSITIVE download Created with Sketch. 232.69KB
DXB Investor Update
11/04/17PRICE SENSITIVE download Created with Sketch. 1.49MB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
52.0¢
Change
0.010(1.96%)
Mkt cap ! $312.0M
Open High Low Value Volume
51.0¢ 52.0¢ 50.0¢ $638.2K 1.243M

Buyers (Bids)

No. Vol. Price($)
5 102060 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
52.0¢ 49580 2
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.